Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04357353 · ClinicalTrials.gov registry record · Phase 3
The Role of Platelet Rich Plasma for Erectile Dysfunction
A Phase 3 study, sponsored by University of Nebraska.
- Terminated
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT04357353: Clinical Trial Phase 3 study, sponsored by University of Nebraska.
NCT04357353 is a Phase 3 study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 13 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04357353, a Phase 3 study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
Primary Outcome
The rate of change in erectile function measured by IIEF
Interventions
- BIOLOGICAL Platelet rich plasma
- OTHER Placebo Sham Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-11-02 |
| Phase | Phase 3 |
Why NCT04357353 stopped before completion
NCT04357353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Platelet rich plasma is the first listed.
NCT04357353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04357353 about?
NCT04357353 is a clinical study titled "The Role of Platelet Rich Plasma for Erectile Dysfunction". Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
What is the current status of trial NCT04357353?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2021-04-01. Estimated completion is 2022-11-02.
What interventions are being tested in trial NCT04357353?
The interventions under investigation include: Platelet rich plasma (BIOLOGICAL), Placebo Sham Injection (OTHER).
Who is sponsoring clinical trial NCT04357353?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04357353's enrollment target sits among peer trials
13 1984th of 2000 higher than 17 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI